research Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
This study found IL-17/IL-36 signaling to be predominant in both endotypes of Netherton syndrome, with distinct molecular profiles between NS-ILC and NS-SE lesions, offering potential therapeutic targets.

